<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00168194</url>
  </required_header>
  <id_info>
    <org_study_id>235/04</org_study_id>
    <nct_id>NCT00168194</nct_id>
  </id_info>
  <brief_title>Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History</brief_title>
  <official_title>Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Alfred</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>The Alfred</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It remains unclear why some individuals are able to clear HBV from their bodies while in
      others HBV is a persistent infection. We plan to investigate this process by collecting blood
      and analysing how the patient's white blood cells respond to different pieces of the HBV
      virus. We will use new tools that can precisely tell us which component of the immune
      response may be different in individuals who are chronically infected with HBV and also in
      individuals who are also infected with HIV.

      The primary aims are therefore:

        1. To characterize HBV-specific T cell responses in HBV chronic carriers, and identify
           novel immunogenic regions in both HLA-A2+ and non-HLA-A2+ individuals.

        2. To determine the effect of HIV infection on HBV-specific T-cell responses
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2004</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">104</enrollment>
  <condition>Hepatitis B</condition>
  <condition>HIV Infections</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        HIV and hepatitis B co-infection
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        There are two groups of patients in this study. Group A mono-infected with Hepatitis B, and
        those with co-infection HBV/HIV.

        Group A inclusion criteria: (also split into 6 recruiting groups)

          -  Acute hepatitis B

          -  Chronic hepatitis B, HBV DNA+ve , normal ALT , HBeAg +ve

          -  Chronic hepatitis B, HBV DNA +ve , normal ALT, HBeAg -ve

          -  Chronic hepatitis , HBV DNA +ve, increased ALT, no HBV treatment B, HBeAg +ve

          -  Chronic hepatitis B, HBV DNA +ve , increased ALT, no HBV treatment B, HBeAg -ve

          -  Chronic hepatitis B, undergoing 'flare' of hepatitis

        Group B inclusion criteria:

          -  To be HIV/HBV co-infected

        All patients:

          -  To be over 18 years

        Exclusion Criteria:

          -  Those who do not fit the inclusion criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sharon Lewin, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Burnet Institute, Melbourne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Alfred Hospital, Commercial Road</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2005</study_first_submitted>
  <study_first_submitted_qc>September 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2005</study_first_posted>
  <last_update_submitted>January 19, 2012</last_update_submitted>
  <last_update_submitted_qc>January 19, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Alfred</investigator_affiliation>
    <investigator_full_name>Jennifer Hoy</investigator_full_name>
    <investigator_title>Professor Jennifer Hoy</investigator_title>
  </responsible_party>
  <keyword>HIV</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Hepatitis B</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

